Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations

International Journal of Cancer. Journal International Du Cancer
T KawasakiT Kumanishi

Abstract

The p53-inducible cyclin-dependent kinase inhibitor, p21/WAF1/CIP1 (p21), plays a pivotal role in the G1 arrest or apoptosis of cells exposed to genotoxic stimuli. To determine whether p21 is a putative tumor-suppressor gene, p21 status was investigated in 4 human bladder-cancer cell lines of known p53 status. A p21-gene mutation, one base-pair insertion at codon 20 resulting in a chain-termination change at codon 35, was observed in one cell line, HT1376, suggesting structural or functional alteration of the p21 protein. When exposed to DNA-damaging agents, cisplatin or mitomycin C, apoptosis was induced in RT4 with the wild-type (wt) p53/wt p21, whereas T24 with the p53 non-sense mutation/wt p21 was resistant. Of the other 2 cell lines with the p53 mis-sense mutation, apoptosis was induced in SCaBER with the wt p21, but HT1376 with the p21 frame-shift mutation was fairly resistant. These findings suggest that not only p53 alteration, but also p21 alteration, is important to prevent apoptosis induced by DNA-damaging agents. When exposed to these agents, p53 and p21 expression was increased in RT4, and not induced in T24. p53 was not induced, but p21 expression was increased in SCaBER, whereas p53 expression was increased but p...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P ShawJ Costa
Jul 5, 1991·Science·M HollsteinC C Harris
Sep 19, 1995·Biochimica Et Biophysica Acta·H WatanabeK Gomi
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Dec 16, 1993·Nature·Y XiongD Beach
May 3, 1996·International Journal of Cancer. Journal International Du Cancer·Y TomitaK G Wiman

❮ Previous
Next ❯

Citations

Jan 5, 2002·Expert Opinion on Investigational Drugs·M C Filion, N C Phillips
Feb 15, 2001·The Journal of Urology·B J DugganUNKNOWN Belfast Uro-oncology Research Group
Sep 24, 2002·Journal of Cellular Biochemistry·Olga GrecoChryso Kanthou
Sep 6, 2000·BJU International·K P JeffersonJ M Holly
Oct 23, 2004·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Simeon SantourlidisWolfgang A Schulz
Jan 15, 1999·British Journal of Cancer·M C FilionN C Phillips
Mar 11, 2011·Radiation Research·Takashi SugiharaKimio Tanaka
Jul 18, 2000·Anti-cancer Drugs·W DempkeH J Schmoll
May 17, 2002·The Journal of Biological Chemistry·Normand BeaulieuA Robert MacLeod
May 8, 1999·BJU International·J D KellyS R Johnston
Jan 22, 2003·In Vitro Cellular & Developmental Biology. Animal·Terence W McGarveyS Bruce Malkowicz
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wainer ZoliDino Amadori
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R P Perez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.